Featured
New Aussie Country Manager named in reshuffle
This pharma has undergone significant leadership changes in recent months, spanning both its global operations and Australian business, with a Country Manager officially named
Featured
Advocacy until the very end: Her final fight for change
CareFully founder, Caitlin Delaney, has passed away and true to her unwavering advocacy, she continued to fight for faster access to medicines, recording a message in her final hours
Jobs & Workplace
Is Australia's pharma workforce at breaking point?
Job losses across Australian pharma have stretched workforces - some to breaking point - with employees who have escaped redundancy, left to pick up the work of one, two, or three or more employees who have left
Leadership & People
Ex-Aussie GM lifts lid on job search
The Australian pharma job market is a journey for everyone, even Country Leaders, as this former boss has revealed
Jobs & Workplace
Medical Directors tackle thorny questions on AI
Twenty Aussie industry leaders gathered for the inaugural Medical Directors Breakfast on AI in Sydney, to unpack how AI is reshaping their teams
Regulatory & Reimbursement
PBAC preps for submission complexities
The Department has released guidance on how to use AI in PBAC submissions and established a rolling review of PBAC guidelines
Featured
Who's nabbed 10 PRIME Award nominations?
Company heads into the PRIME Awards next week as a finalist for a staggering 10 campaigns across four categories. This is how they did it...
Industry & Companies
Pharma spend on HCPs shrinks
Companies lowered the amount they spent on HCPs each month in the first half of 2026, with just two pharmas getting into seven figures
Pipeline & Intellectual Property
That was fast: Celairis to pay $10.3M for first drug
In its first major deal just days after launching, Matt Zeller and Damian Clarke-Bruce's company has added an investigational one-time gene therapy to its pipeline
Industry & Companies
Satchel puts blister pack recycling within reach
Consumer Healthcare Products Australia and its members have come together with Pharmacycle to take blister pack recycling to the next level
Jobs & Workplace
Companies line up talent for 2027
There's been a wave of movement across Australian pharma with promotions, new hires, departures and even a retirement as a new year looms
Industry & Companies
Scam headhunters targeting Aussie pharma execs
Scammers impersonating legitimate Big Pharma in-house recruiters are targeting Australian industry professionals with lucrative high-income roles as part of a money-making racket
Leadership & People
Ex-CSL exec steps into CEO role
After eight-plus years with the Aussie giant, this industry leader has taken a CEO role at a biotech with big ambitions to transform precision medicine
Regulation & Legal
Novartis gene therapy hit by cancer fears
A theoretical side-effect of the gene therapy has appeared in practice, alarming patient networks around the world
Sales, Marketing & Public Relations
New access model reshaping pharma
Direct-to-patient programs are considered "mission critical" according to a third of pharma professionals who believe it will transform access
Pipeline & Intellectual Property
Supply setback extends shortage into 2027
A national shortage of this treatment is expected to continue into 2027 after the pharma confirmed an order, expected this month, is now “unlikely”
Jobs & Workplace
Pharma urged to grow Aussie workforce
New report on the Australian clinical trials workforce reveals the same people are either being reshuffled or lost, while others struggle to crack the market
Industry & Companies
Was this Aussie pharma's Best Kept Secret?
A bombshell announcement from two industry high-flyers was kept completely under wraps despite multiple big-name organisations getting on board with the new pharma venture. And now, they've detailed a potentially market-disrupting business model for medicines access
Industry & Companies
Pharma sold at undisclosed price
An international private equity firm has reached an agreement to acquire this pharma, with plans to support its global growth ambitions
Patients
Riders pedal past fundraising target
Aussie BMS staffers have raised double their original goal for Rare Cancers Australia through an 18,000 kilometre, 15-day cycling event in Japan
Jobs
Featured
Matt Zeller launches new Australian pharma
Five months after leaving Arrotex, the former Novartis Country President ANZ is launching his own Sydney-headquartered pharma company with another high-profile exec as Co-Founder
Government & Policy
Boosting PBS spending a political no-brainer
New research commissioned by Pfizer Australia exposes near-universal public support for expanding the PBS among Coalition, Labor, Greens and One Nation voters
Industry & Companies
Roche unveils new tech for high-throughput genomics
The Swiss pharma is gathering experts to push its entrant into the booming next-generation sequencing market
Regulatory & Reimbursement
New drugs flood the ARTG
Last week saw a string of medicines registered on the ARTG, including two heart drugs, a new contraceptive option, and Novo’s hyped obesity pill
Leadership & People
Pfizer names permanent ANZ leader
He knows plenty about the role, having served as interim Managing Director for six months, now this leader has officially landed the top job, providing certainty for the pharma as it navigates a changing reimbursement landscape
Sales, Marketing & Public Relations
What doctors really want Reps to talk about
More than four in 10 clinicians say conversations with reps are mostly about products but what they'd really like to discuss is this...
Leadership & People
Country boss adds new leadership hat
AstraZeneca leader joins board to promote trade between Europe and Australia bolstering collaboration, innovation and investment
Regulatory & Reimbursement
Drugs dropped from PBAC meeting
Three drugs were removed and another added in a last-minute revision to the agenda for the PBAC's last three-day meeting for 2026
Industry & Companies
Pharma sells off Aussie business
This company will now be a specialty pharma focused on the United States with its Australian assets moving to new hands for $55M
Patients
Omico names genomic profiling partners
Four organisations have been selected to provide comprehensive genomic profiling for 25,000 Australians in the next phase of this screening program
Pipeline & Intellectual Property
Pharma signs its biggest ever milestones deal
Mega license agreement inked with Chinese powerhouse covering six antibody-drug conjugate and T-cell engager programs
- Industry & Companies One webpage, 11 Code Breaches
- Regulatory & Reimbursement 11 drugs join TGA review list
- Regulatory & Reimbursement What drugs are on MS patients' Wish List?
- Pipeline & Intellectual Property Can pharma sustain the blockbuster boom?
- Government & Policy Blue wave to break against MFN
- Pipeline & Intellectual Property Drug fails four months after $2.2B upfront buy
- Jobs & Workplace Aussies tapped for regional roles
- Regulatory & Reimbursement Pharmac says no to weight loss funding
- Regulatory & Reimbursement Aussie race to market kicks off for obesity pills
- Industry & Companies Who's opening its doors in the US?